204 related articles for article (PubMed ID: 11246299)
1. Variability among institutional review boards' decisions within the context of a multicenter trial.
Silverman H; Hull SC; Sugarman J
Crit Care Med; 2001 Feb; 29(2):235-41. PubMed ID: 11246299
[TBL] [Abstract][Full Text] [Related]
2. Research consent by adolescent minors and institutional review boards.
Mammel KA; Kaplan DW
J Adolesc Health; 1995 Nov; 17(5):323-30. PubMed ID: 8924437
[TBL] [Abstract][Full Text] [Related]
3. Variation in institutional review board responses to a standard protocol for a multicenter clinical trial.
Stair TO; Reed CR; Radeos MS; Koski G; Camargo CA;
Acad Emerg Med; 2001 Jun; 8(6):636-41. PubMed ID: 11388939
[TBL] [Abstract][Full Text] [Related]
4. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
5. Inconsistency and institutional review boards.
Goldman J; Katz MD
JAMA; 1982 Jul; 248(2):197-202. PubMed ID: 7045428
[TBL] [Abstract][Full Text] [Related]
6. Variation in standards of research compensation and child assent practices: a comparison of 69 institutional review board-approved informed permission and assent forms for 3 multicenter pediatric clinical trials.
Kimberly MB; Hoehn KS; Feudtner C; Nelson RM; Schreiner M
Pediatrics; 2006 May; 117(5):1706-11. PubMed ID: 16651328
[TBL] [Abstract][Full Text] [Related]
7. Readability standards for informed-consent forms as compared with actual readability.
Paasche-Orlow MK; Taylor HA; Brancati FL
N Engl J Med; 2003 Feb; 348(8):721-6. PubMed ID: 12594317
[TBL] [Abstract][Full Text] [Related]
8. Informed consent for research on stored blood and tissue samples: a survey of institutional review board practices.
White MT; Gamm J
Account Res; 2002; 9(1):1-16. PubMed ID: 12705242
[TBL] [Abstract][Full Text] [Related]
9. Variation of community consultation and public disclosure for a pediatric multi-centered "Exception from Informed Consent" trial.
Holsti M; Zemek R; Baren J; Stanley RM; Mahajan P; Vance C; Brown KM; Gonzalez V; King D; Jacobsen K; Shreve K; van de Bruinhorst K; Jones AM; Chamberlain JM
Clin Trials; 2015 Feb; 12(1):67-76. PubMed ID: 25369796
[TBL] [Abstract][Full Text] [Related]
10. Clinical Research in Vulnerable Populations: Variability and Focus of Institutional Review Boards' Responses.
Kästner B; Behre S; Lutz N; Bürger F; Luntz S; Hinderhofer K; Bendszus M; Hoffmann GF; Ries M
PLoS One; 2015; 10(8):e0135997. PubMed ID: 26275228
[TBL] [Abstract][Full Text] [Related]
11. Problematic variation in local institutional review of a multicenter genetic epidemiology study.
McWilliams R; Hoover-Fong J; Hamosh A; Beck S; Beaty T; Cutting G
JAMA; 2003 Jul; 290(3):360-6. PubMed ID: 12865377
[TBL] [Abstract][Full Text] [Related]
12. Minimal-risk waiver of informed consent and exception from informed consent (Final Rule) studies at institutional review boards nationwide.
Ernst AA; Weiss SJ; Nick TG; Iserson K; Biros MH
Acad Emerg Med; 2005 Nov; 12(11):1134-7. PubMed ID: 16264084
[TBL] [Abstract][Full Text] [Related]
13. Problems with Institutional Review Board inconsistency.
Veatch RM
JAMA; 1982 Jul; 248(2):179-80. PubMed ID: 7045427
[TBL] [Abstract][Full Text] [Related]
14. Consent form heterogeneity in cancer trials: the cooperative group and institutional review board gap.
Koyfman SA; Agre P; Carlisle R; Classen L; Cheatham C; Finley JP; Kuhrik N; Kuhrik M; Mangskau TK; O'Neill J; Reddy CP; Kodish E; McCabe MS
J Natl Cancer Inst; 2013 Jul; 105(13):947-53. PubMed ID: 23821757
[TBL] [Abstract][Full Text] [Related]
15. Variability among institutional review boards and the value of local research context.
Clark DC
Crit Care Med; 2001 Feb; 29(2):444-5. PubMed ID: 11246330
[No Abstract] [Full Text] [Related]
16. Variability in IRBs regarding parental acceptance of passive consent.
Higgerson RA; Olsho LE; Christie LM; Rehder K; Doksum T; Gedeit R; Giuliano JS; Brennan B; Wendlandt R; Randolph AG;
Pediatrics; 2014 Aug; 134(2):e496-503. PubMed ID: 25002659
[TBL] [Abstract][Full Text] [Related]
17. Regulatory overview: protection of human subjects--IRBS and informed consent.
Nightingale SL
Drug Inf J; 1987; 21(2):109-15. PubMed ID: 10282111
[TBL] [Abstract][Full Text] [Related]
18. Breaking the camel's back: multicenter clinical trials and local institutional review boards.
Burman WJ; Reves RR; Cohn DL; Schooley RT
Ann Intern Med; 2001 Jan; 134(2):152-7. PubMed ID: 11177319
[TBL] [Abstract][Full Text] [Related]
19. Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial.
Marquis-Gravel G; Robertson H; Jones WS; Riley D; Ford DE; Crenshaw D; Joosten YA; Rudov L; Hernandez AF; Hess R
Trials; 2021 Jan; 22(1):90. PubMed ID: 33494785
[TBL] [Abstract][Full Text] [Related]
20. Structure and practice of institutional review boards in the United States.
Jones JS; White LJ; Pool LC; Dougherty JM
Acad Emerg Med; 1996 Aug; 3(8):804-9. PubMed ID: 8853678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
